Cargando…
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Predicting the outcome of immunotherapy treatment in melanoma patients is challenging. Alterations in genes involved in antigen presentation and the interferon gamma (IFNγ) pathway play an important role in the immune response to tumors. We describe here that the overexpression of PSMB8 and PSMB9, t...
Autores principales: | Kalaora, Shelly, Lee, Joo Sang, Barnea, Eilon, Levy, Ronen, Greenberg, Polina, Alon, Michal, Yagel, Gal, Bar Eli, Gitit, Oren, Roni, Peri, Aviyah, Patkar, Sushant, Bitton, Lital, Rosenberg, Steven A., Lotem, Michal, Levin, Yishai, Admon, Arie, Ruppin, Eytan, Samuels, Yardena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021791/ https://www.ncbi.nlm.nih.gov/pubmed/32060274 http://dx.doi.org/10.1038/s41467-020-14639-9 |
Ejemplares similares
-
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021) -
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2018) -
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2019) -
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
por: Kalaora, Shelly, et al.
Publicado: (2016) -
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
por: Wolf, Yochai, et al.
Publicado: (2019)